Johnson & Johnson dose allocation to fall 85% next week; Notre Dame latest university to require vaccination: Latest COVID-19 updates Elinor Aspegren, USA TODAY
Replay Video UP NEXT
The allocation of Johnson & Johnson vaccine doses from the U.S. government is expected to fall by 85% next week, reported the Centers for Disease Control and Prevention.
The decline in supply comes after the company had to discard 15 million doses of its coronavirus vaccine last month because the batch did not meet quality standards.
Pfizer-BioNTech and Moderna vaccine dose distribution will remain steady, with 4.7 million first doses of Pfizer and 3.5 million first doses of Moderna allocated to states.
UK infections drop 60 per cent amid vaccinations, lockdown
jamaicaobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from jamaicaobserver.com Daily Mail and Mail on Sunday newspapers.
Pfizer asks FDA to OK its vaccine for kids ages 12-15; Coney Island’s famed amusement parks reopen: Latest COVID-19 updates Elinor Aspegren, Kaanita Iyer, Doyle Rice and Karen Weintraub, USA TODAY
Can the traumas of COVID-19 make us stronger?
Replay Video UP NEXT
Pfizer and its German collaborator BioNTech on Friday asked for the U.S. Food and Drug Administration to allow their COVID-19 vaccine to be used on adolescents ages 12-15. Their vaccine is already authorized for those 16 and up.
The companies also plan to ask for similar authorization from regulatory agencies in other parts of the world. In trial results released recently, the companies showed that their vaccine prevented all COVID-19 symptomatic disease in trial participants ages 12-15, generated large numbers of protective antibodies in that age group, and did not pose any safety concerns.
Johnson & Johnson dose allocation to fall 85% next week; Notre Dame latest university to require vaccination: Latest COVID-19 updates Elinor Aspegren, USA TODAY
Replay Video UP NEXT
The allocation of Johnson & Johnson vaccine doses from the U.S. government is expected to fall by 85% next week, reported the Centers for Disease Control and Prevention.
The decline in supply comes after the company had to discard 15 million doses of its coronavirus vaccine last month because the batch did not meet quality standards.
Pfizer-BioNTech and Moderna vaccine dose distribution will remain steady, with 4.7 million first doses of Pfizer and 3.5 million first doses of Moderna allocated to states.
Pfizer asks FDA to OK its vaccine for kids ages 12-15; Coney Island’s famed amusement parks reopen: Latest COVID-19 updates Elinor Aspegren, Kaanita Iyer, Doyle Rice and Karen Weintraub, USA TODAY
Can the traumas of COVID-19 make us stronger?
Replay Video UP NEXT
Pfizer and its German collaborator BioNTech on Friday asked for the U.S. Food and Drug Administration to allow their COVID-19 vaccine to be used on adolescents ages 12-15. Their vaccine is already authorized for those 16 and up.
The companies also plan to ask for similar authorization from regulatory agencies in other parts of the world. In trial results released recently, the companies showed that their vaccine prevented all COVID-19 symptomatic disease in trial participants ages 12-15, generated large numbers of protective antibodies in that age group, and did not pose any safety concerns.
vimarsana © 2020. All Rights Reserved.